Santiago A. Lozano-Calderon, MD PhD (he/him/his)

Associate Professor of Orthopaedic Surgery
Massachusetts General Hospital, Harvard Medical School

I received my MD from Pontificia Universidad Javeriana Medical School in Bogotá, Colombia in 2001 and my PhD from the University of Amsterdam in 2008. I completed my Orthopaedic Surgery Residency at New York Medical College Westchester Medical Center in 2012. In 2013, I completed my musculoskeletal oncology fellowship training via the Harvard Combined Musculoskeletal Oncology Fellowship. I am now an Associate Professor of Orthopaedic Surgery at Harvard Medical School and an Attending Orthopaedic Oncology Surgeon at Massachusetts General Hospital. Currently, I serve as program director of the Harvard Combined Musculoskeletal Oncology Fellowship.

Poster(s):

• (P 63) DOES TUMOR NECROSIS IMPACT PROGNOSIS IN CHONDROBLASTIC AND OSTEOBLASTIC OSTEOSARCOMA? A STUDY FROM A LARGE TERTIARY CARE ACADEMIC CENTER

• (P 100) ADVANCING PROGNOSTICS IN ONCOLOGY: MACHINE LEARNING MODELS FOR PREDICTING 2-YEAR AND 5-YEAR SURVIVAL RATES IN PATIENTS WITH UNDIFFERENTIATED PLEOMORPHIC SARCOMA

• (P 107) DOES THE USE OF ADJUVANT CHEMOTHERAPY IN LOCALIZED, RESECTABLE SOFT TISSUE SARCOMA LEAD TO BETTER SURVIVAL OUTCOMES? - A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

• (P 108) FIXATION OF IMPENDING OR PATHOLOGIC FRACTURES DUE TO METASTATIC DISEASE WITH CARBON FIBER INTRAMEDULLARY NAILS-A PROPENSITY-SCORE MATCHED COST ANALYSIS

• (P 284) WOUND VAC TEMPORIZATION AFTER TUMOR RESECTION OF SOFT TISSUE SARCOMAS - A COST ANALYSIS IN A PROPENSITY-SCORE MATCHED POPULATION